Faculty Disclosures
| Mitchell S. Elkind, MD, MS, FAAN |
Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. |
| Yedatore S. Venkatesh, MD, FAAN |
Dr. Venkatesh has nothing to disclose. |
| Ben Wakerley, MD |
No disclosure on file
|
| Vijay Sharma |
No disclosure on file
|
| Osama O. Zaidat, MD, FAAN |
Dr. Zaidat has nothing to disclose. |
| Loh Pei Kee, MD |
No disclosure on file
|
| Dileep R. Yavagal, MD, FAAN |
Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line. |
| Eliahu S. Feen, MD |
No disclosure on file
|
| Ali R. Malek, MD |
No disclosure on file
|
| Prakash R. Paliwal, MD |
No disclosure on file
|
| Aftab Ahmad, MD |
Dr. Ahmad has nothing to disclose. |
| Ritesh Kaushal, MD, PhD |
Dr. Kaushal has nothing to disclose. |
| Johannes C. Wohrle, MD |
No disclosure on file
|
|
No disclosure on file
|
| Amer Alshekhlee, MD |
No disclosure on file
|
| Salvador Cruz-Flores, MD, FAAN |
The institution of Dr. Cruz-Flores has received research support from University of Texas System. |
| Muhammad F. Suri, MD |
Dr. Suri has nothing to disclose. |
| David E. Blum, MD |
Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics. |
| Gustavo J. Rodriguez, MD |
Dr. Rodriguez has nothing to disclose. |
| William J. Powers, MD, FAAN |
Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities. |
| Wondwossen G. Tekle, MD |
Dr. Tekle has nothing to disclose. |
| Saqib A. Chaudhry, MD |
Dr. Chaudhry has nothing to disclose. |
| Ganesh Asaithambi, MD, FAAN |
Dr. Asaithambi has nothing to disclose. |
| Ameer Hassan, DO |
Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare. |
| Hamza I. Maqsood, MD |
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Rafael Ortiz, MD |
No disclosure on file
|
| Arani Bose, MD |
No disclosure on file
|
| Sonal Mehta, MD |
Dr. Mehta has nothing to disclose. |
| Hailong Cheng |
No disclosure on file
|
| Ralph Werner, MD |
No disclosure on file
|
| Wei Ping Kay Ng, MD |
Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. |
| Nazli A. Janjua, MD, MBBS |
Dr. Janjua has nothing to disclose. |
| Leonard L. Yeo, MBBS |
The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC. |
| Philippe Ryvlin, MD, PhD |
Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe). |
| Todd Grinnell, PhD |
Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.. |
| Francisco Rocha |
Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela. |
| Helena Gama |
Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A.. |